These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1806631)

  • 1. A review of fluvoxamine and its uses in depression.
    Burton SW
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():1-17; discussion 17-21. PubMed ID: 1806631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.
    Wilde MI; Plosker GL; Benfield P
    Drugs; 1993 Nov; 46(5):895-924. PubMed ID: 7507038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine: a review of the controlled trials in depression.
    Ware MR
    J Clin Psychiatry; 1997; 58 Suppl 5():15-23. PubMed ID: 9184623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The elderly depressed and treatment with fluvoxamine.
    Phanjoo A
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():33-7; discussion 37-9. PubMed ID: 1806633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fluvoxamine in severe depression.
    Mendlewicz J
    Drugs; 1992; 43 Suppl 2():32-7; discussion 37-9. PubMed ID: 1378372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
    Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of fluvoxamine in patients with severe depression.
    Ottevanger EA
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):731-40. PubMed ID: 7938563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label pilot study of fluvoxamine for mixed anxiety-depression.
    Houck C
    Psychopharmacol Bull; 1998; 34(2):225-7. PubMed ID: 9641005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.
    Goodman WK; Price LH; Rasmussen SA; Delgado PL; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1989 Jan; 46(1):36-44. PubMed ID: 2491940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects.
    Grassi B; Gambini O; Scarone S
    Pharmacopsychiatry; 1995 May; 28(3):93-4. PubMed ID: 7568371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of major affective disorder with fluvoxamine.
    Lapierre YD; Browne M; Horn E; Oyewumi LK; Sarantidis D; Roberts N; Badoe K; Tessier P
    J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients.
    Laird LK; Lydiard RB; Morton WA; Steele TE; Kellner C; Thompson NM; Ballenger JC
    J Clin Psychiatry; 1993 Jun; 54(6):224-8. PubMed ID: 8331091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of antidepressants.
    Kasper S; Fuger J; Möller HJ
    Drugs; 1992; 43 Suppl 2():11-22; discussion 22-3. PubMed ID: 1378369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J
    Acta Psychiatr Scand; 1988 Dec; 78(6):668-75. PubMed ID: 3146890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between fluvoxamine and imipramine/desipramine in four patients.
    Spina E; Campo GM; Avenoso A; Pollicino MA; Caputi AP
    Ther Drug Monit; 1992 Jun; 14(3):194-6. PubMed ID: 1412604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.
    Rossini D; Serretti A; Franchini L; Mandelli L; Smeraldi E; De Ronchi D; Zanardi R
    J Clin Psychopharmacol; 2005 Oct; 25(5):471-5. PubMed ID: 16160624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.